ICE-guided structural heart interventions | Medtronic's new 3-in-1 stent | TTVR after a heart transplant | Shock-related deaths

ICE is gaining momentum as a helpful imaging option during structural heart interventions, according to a new SCAI position statement. TEE and TTE remain incredibly important, but there are times when ICE can provide the guidance necessary.

The device, manufactured by Contego Medical, was designed with rising procedure volumes and stroke risks in mind. 

When a 50-year-old patient developed severe TR just months after receiving a heart transplant, the safest treatment option was to implant an Evoque TTVR device. 

The balloon-free catheter, which already had a successful launch in the United States, has been associated with positive outcomes and the ability to reach certain lesions more accurately than balloon-based IVL platforms.

The new initiative aims to provide shock teams with objective data that can guide early management decisions and reduce mortality rates. 

There have been so many developments in the treatment of TR that it can be challenging to keep up. The ACC crafted this new document to help ensure cardiologists, cardiac imagers and other clinicians have access to the most recent clinical data and policy decisions.

Using an Impella heart pump during high-risk PCI was linked to a reduced short-term mortality rate and an acceptable safety profile.

Mount Sinai Fuster Heart Hospital aims to take its use of AI during interventional procedures to the next level and find new ways to transform patient care.